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Abstract
Objective The lack of suitable antibodies for the histamine
inactivating enzyme histamine N-methyltransferase (HMT)
has so far prevented the direct analysis of HMT proteins in
man and other mammals.
Methods A series of monoclonal antibodies was produced
by immunizing mice with human and porcine HMT
expressed in vitro. Antibodies were characterized by
immunoblotting and immunohistochemical staining.
Results Six different monoclonal antibodies specific for
human HMT and four different monoclonal antibodies
specific for porcine HMT were obtained that can detect
HMT with up to tenfold greater sensitivity than the most
sensitive enzymatic assays currently available. Using these
antibodies allowed us to confirm the expression and cel-
lular localization of HMT in various human and porcine
tissues, where the presence of the enzyme had previously
been deduced from activity measurement and HMT mRNA
analysis. Immunohistochemical staining of human and
porcine tissue sections clearly showed that HMT is a
cytosolic protein, which is localized in specific cells of
most mammalian tissues.
Conclusions The new monoclonal antibodies not only
allow a comprehensive quantitative evaluation of the
expression of HMT at the cellular level in man and other
mammals but will also facilitate sensitive analyses of dis-
ease-associated alterations of this protein.
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Histamine is an important mediator of many biological
processes including inflammation, gastric acid secretion,
neuromodulation, and regulation of immune function acting
through four different G-protein-coupled receptors [1, 2].
Due to its potent pharmacological activity at very low
concentrations, the synthesis, transport, storage, release and
degradation of histamine have to be carefully regulated to
avoid undesirable reactions. Histamine is formed by decar-
boxylation of the amino acid L-histidine in a reaction
catalyzed by the enzyme histidine decarboxylase (HDC, EC
4.1.1.22) [3, 4]. The major routes of histamine inactivation
in mammals are oxidative deamination of the primary amino
group, catalyzed by diamine oxidase (DAO, EC 1.4.3.22),
and methylation of the imidazole ring, catalyzed by his-
tamine N-methyltransferase (HMT, EC 2.1.1.8) [4–6].
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HMT catalyzes the transfer of a methyl group from
S-adenosyl-L-methionine (SAM) to the secondary amino
group of the imidazole ring of histamine forming Ns-
methylhistamine [6]. Human HMT is a small monomeric
protein of 33 kDa consisting of a single polypeptide chain
of 292 amino acid residues. HMT does not appear to carry
any modifications and the enzyme does not require any
cofactors for its activity. HMT has a two-domain structure
with the larger N-terminal domain being a classic
methyltransferase fold with an SAM binding motif [7].
Human HMT is encoded by a single gene designated
HNMT that has six exons and has been mapped to chro-
mosome 2q22.1 [8]. HMT is highly specific for histamine
and does not show significant methylation of other sub-
strates. Apart from its reaction products, the enzyme is
strongly inhibited by the SH-group reagents p-chloromer-
curibenzoate and N-ethylmaleimide and by the antimalarial
drugs quinacrine and amodiaquine [6]. HMT appears to be
a cytosolic protein that is responsible for the inactivation of
intracellular histamine, which is either synthesized in the
cell or taken up from the extracellular space after binding
to one of its receptors present on the cell surface or by
plasma membrane transporters [4].
Histamine N-methyltransferase is detectable in most
tissues of mammals by activity measurements or mRNA
analysis experiments [9–11] but the expression and cellular
localization of the protein have not been determined for
most tissues especially in man, which is mainly due to the
lack of antibodies specific for HMT. Recently, we suc-
ceeded in making antibodies for porcine and human DAO,
the enzyme catalyzing the alternative route of histamine
inactivation, and these turned out to be invaluable tools for
the study of this enzyme [12, 13]. To close the gaps in our
knowledge of HMT expression, localization and function,
we therefore, set out to produce highly sensitive and
specific monoclonal antibodies also for the human and
porcine HMT proteins.
Materials and methods
Preparation of recombinant HMT proteins
Full-length human and porcine HMT cDNAs [9, 10, 14]
were amplified by PCR with specific primers from total
human and porcine kidney cDNA, respectively, and cloned
in frame into the bacterial expression vector pGEX-2T (GE
Healthcare, Vienna, Austria). Each recombinant plasmid
was transformed into the protease-deficient strain E. coli
BL21 to produce glutathione S-transferase (GST) fusion
proteins according to manufacturer’s instructions (GE
Healthcare, Vienna, Austria). Briefly, recombinant bacteria
were grown at 37 C with slight agitation (100 rpm) in
500 ml YTA (16 g/l tryptone, 10 g/l yeast extract, 5 g/l
NaCl, 100 mg/l ampicillin, pH 7.0) to an OD600 nm of 0.5
and fusion protein expression was induced for 4 h by
addition of 0.1 mM isopropyl-b-D-thiogalactopyranoside
(IPTG, Roche, Vienna, Austria). Bacteria were harvested
by centrifugation for 5 min at 4000g, 4 C, washed with
cold deionized water, and lysed in lysis buffer (20 mM
bisTrisHCl, pH 7.0, 5 mM dithiothreitol) containing
Complete Protease Inhibitor Cocktail (Roche, Vienna,
Germany) using a French Press at 600 psi. Both constructs
were expressed at high levels and produced largely soluble
fusion proteins that were recovered from the supernatants
of bacterial lysates after centrifugation for 5 min at 5000g,
4 C and purified to near homogeneity by chromatography
on glutathione sepharose (GSTrap FF, GE Healthcare,
Vienna, Austria) according to manufacturer’s instructions.
The purified GST fusion proteins, which had a similar
HMT enzymatic activity as the enzyme prepared from
kidney tissue [15] were dialyzed against PBS buffer
(10 mM NaH2PO4, pH 7.2, 150 mM NaCl) and used for
immunizations.
Generation of HMT specific antibodies
Balb/c mice (n = 2–4) were immunized i.p. four to five
times with recombinant antigens GST-huHMT and GST-
piHMT, respectively, (Fig. 1) mixed with alhydrogel
(9.8 mg/ml). Each mouse received 20 lg antigen ? 1 mg
Al(OH)3 per injection. After the second and the following
injections serum samples were collected and tested by
ELISA for the presence of antibodies. When the titer had
increased to a level above 1:10,000, selected mice received
an i.p. injection of 20 lg antigen in physiological saline
(150 mM NaCl). After 4 days, the mice were sacrificed and
the spleens removed. Homogenization and disintegration of
the spleens, fusion and cloning followed standard proce-
dures essentially as described earlier [16], except that the
use of fibroblast feeder cells was substituted with
HybERTM medium (SSI, Copenhagen, Denmark). Animal
experiments were carried out in accordance with the
European Communities Council Directive of 24 November
1986 (86/609/EEC) and were approved by local authorities.
For testing antibody titers by ELISA, antigens (0.5 lg/
ml) were coated in Maxisorp plates (Nunc, Denmark) using
100 ll 50 mM sodium carbonate buffer, pH 9.6 per well.
All subsequent blocking (5 min), washing (3 9 5 min) and
incubation (60 min) steps were done in TTN buffer
(25 mM Tris, pH 7.5, 0.5 % Tween 20, 150 mM NaCl).
After blocking, wells were incubated 60 min with sera
(starting dilution 1:200 and 29 titrations) or culture
supernatants and after washing, wells were incubated
60 min with alkaline phosphatase-conjugated goat IgG
against mouse IgG (Sigma, St. Louis, USA). Finally, wells
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man LWDFLTETCNFNATAPPDLRAELGKDLQEPEFSAKKEGKVLFNNTLSFIVIEA 100%
pig LWDFLTETCHFNATAPPDLKEEIMKDLQEPEFSVKKGGKVLFNNSLSFIVVWG                        87%
mouse LWDFLTETCNFSKTAPLDLKAEIMKDLQEPEFSVKKEGKVLFNNNLSFIVVEANV                      84%
rat LWDFLTETCNFIKTAPLDLKEEIMKDLQEPEFSVKKEGKVLFNNNLSFIVVEANV                      84%
huHMT piHMT
Fig. 1 Recombinant HMT antigens used for immunizations. a Re-
combinant human and porcine GST-HMT fusion proteins cloned in
the bacterial expression vector pGEX-2T. b 12.5 % Silver-stained
polyacrylamide gel of the purified human (lane 1) and porcine (lane
3) GST-HMT fusion proteins used for the immunization of mice and
the HMT and GST products resulting from cleavage with thrombin
protease (lanes 2 and 4). The sizes of molecular weight markers
(M) are given on the left in kilodalton. c Sequence alignment and
percent sequence identity of the HMT proteins from man, pig, mouse
and rat obtained with the NCBI Constrained-based Multiple Align-
ment Tool (www.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi?link_loc=
BlastHomeLink). Residues identical in all four proteins are shaded
black, residues identical in three proteins are shaded gray, and resi-
dues that have been shown to interact with histamine and
S-adenosylhomocysteine in human HMT [7] are shaded red (indi-
cated by plus symbol on top) and blue (indicated by hash on top),
respectively. Antigenicity plots of human (d) and porcine (e) HMT
produced with the BepiPred Linear Epitope Prediction Tool (www.
tools.immuneepitope.org/bcell) [32] show similar predicted B-cell
epitopes (yellow peaks on top of the threshold line with reference to
amino acid positions) for both protein sequences
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were incubated with para-nitrophenyl phosphate (1 mg/ml)
in 1 M diethanolamine, pH 9.8 and the absorbance read at
405 nm with background subtraction at 690 nm. The titer
of a serum was defined as the dilution giving half maximal
absorbance.
Characterization of HMT specific antibodies
Selected antibody clones (hybridoma culture supernatants
or affinity purified immunoglobulins) were further tested
for binding specificity and sensitivity using filter strips of
human and porcine tissue homogenates. Tissue homo-
genates were prepared using the AllPrep DNA/RNA/
Protein Mini Kit (Qiagen, Hilden, Germany) and dissolving
the total precipitated protein in BUD (20 mM bis.Tris.HCl,
pH 7.0, 8 M urea, 50 mM dithiothreitol). The protein was
diluted with SDS sample buffer and 100 lg was separated
on a 10 % SDS polyacrylamide gel [17] and blotted onto a
polyvinylidene fluoride (PVDF) membrane [18]. After
washing in TBST (50 mM Tris.HCl, pH 7.5, 150 mM
NaCl, 0.1 % Tween 20) and blocking non-specific binding
sites by incubation for 60 min at 4 C in TBSTM (TBST
containing 2 % non-fat dry milk) the membrane was cut
into 20 vertical filter strips each containing circa 5 lg of
protein. Each filter strip was incubated for 2–16 h at 4 C
with different dilutions of the monoclonal antibodies in
TBSTM, washed 4 9 5 min with TBST, incubated 60 min
at 4 C with horseradish peroxidase-conjugated anti-mouse
immunoglobulins (Dako, Glostrup, Denmark) diluted
1:1500 in TBSTM, washed 4 x 5 min with TBST, incu-
bated 5 min with ECL or ECL Prime reagent (GE
Healthcare, Vienna, Austria), and exposed to Cronex 5 film
(Agfa, Mortsel, Belgium).
For analyses of HMT in human tissues and body fluids,
we used homogenates of the macroscopically healthy part
of surgical specimens not needed for histopathological
evaluation as well as blood and urine samples from healthy
volunteers (N = 10, 5 male, age 23–49). Tissue samples
were immediately frozen and stored at -25 C until ana-
lyzed. Tissue samples (1–5 mg) were homogenized in 10
volumes of 20 mM bisTrisHCl, pH 7.0 containing 10 mM
dithiothreitol and Complete Protease Inhibitor Cocktail
(Roche, Vienna, Austria) for 5 min at 30 Hz using a Tis-
sueLyser II homogenizer (Qiagen, Hilden, Germany). The
homogenate was cleared by centrifugation for 10 min at
20,000g, 4 C and the supernatant containing the total
soluble protein was stored at -25 C until analyzed. Blood
samples drawn from the antecubital vein were allowed to
clot for at least 2 h at 4 C, centrifuged for 10 min at
1500g, 4 C and the clear serum was stored at -25 C until
analyzed. Urine samples were cooled on ice, centrifuged
for 10 min at 20,000g, 4 C and the clear supernatant was
stored at -25 C until analyzed. Protein concentration of
all samples was determined by the Bradford method [19]
using a commercial kit (Biorad, Vienna, Austria). Proteins
in different samples were characterized by SDS polyacry-
lamide gel electrophoresis (SDS-PAGE) [17] or by two-
dimensional isoelectric focusing (IEF)/SDS-PAGE [20]
and the presence of HMT was analyzed by Western blot-
ting onto PVDF membranes essentially as described for the
filter strips above, using the mouse monoclonal antibodies
at optimum concentrations. HMT activity was determined
by transmethylation of histamine with S-adenosyl-L-
[methyl-14C]methionine (GE Healthcare, Vienna, Austria)
as described previously [21] and the specific activity was
calculated in microunits per milligram protein where 1 lU
converts 1 pmol of substrate per minute at 37 C. All
human samples were obtained for two separate studies
approved by the Ethical Committee of the Medical
University Innsbruck and carried out in compliance with
the Declarations of Helsinki and Istanbul and were ana-
lyzed here anonymized without access to patient data.
Immunohistochemical staining
For immunohistochemical staining, tissues were fixed for
16–24 h in 4 % paraformaldehyde and embedded in
paraffin wax. Sections of 5 lm were cut, mounted on
silanized glass slides (Menzel, Braunschweig, Germany),
and dried 16 h at 50 C. Slides were dewaxed 4 9 3 min
in xylol, 1 9 3 min each in 100 % ethanol, 96 % ethanol,
and 80 % ethanol, rinsed for 5 min with water, and auto-
claved for 10 min at 121 C in 10 mM sodium citrate pH
6.0 for antigen retrieval. Slides were washed 29 with TBS
(50 mM Tris.HCl, pH 7.5, 150 mM NaCl) and mounted on
Coverplates in Coverplate Racks (Thermo Fisher Scien-
tific, Vienna, Austria) for subsequent incubations. Each
incubation step was followed by three washes with TNT
(TBS containing 0.05 % Tween 20). Endogenous peroxi-
dase activity was blocked by incubation in 1 % H2O2 for
15 min, endogenous biotin was blocked employing the
Biotin Blocking System (Dako, Glostrup, Denmark), and
non-specific protein binding sites were blocked by incu-
bation in TNB (TBS containing 0.5 % Blocking Reagent,
PerkinElmer, Rodgau, Germany) for 30 min. Slides were
incubated for 16 h at 4 C with the mouse monoclonal
antibodies for human or porcine HMT diluted
1:100–1:1500 in TNB and then for 2 h a 25 C with
horseradish peroxidase-conjugated anti-mouse
immunoglobulins (Dako, Glostrup, Denmark) diluted
1:100 in TNB. The Tyramide Signal Amplification System
(PerkinElmer, Rodgau, Germany) was used according to
manufacturer’s instructions for signal amplification. For
staining of immunocomplexes, slides were incubated for
5 min with DAB substrate (0.05 % 3,30-diaminobenzidine,
0.01 % H2O2, 50 mM TrisHCl, pH 7.6) and
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counterstained with Mayer’s hemalum (Merck, Darmstadt,
Germany). Slides were dehydrated by incubation for 3 min
each in 70 % ethanol, 80 % ethanol, 96 % ethanol, 29
100 % ethanol, and 29 xylol and coverslips were mounted
with Entellan (Merck, Darmstadt, Germany).
Results
Using GST fusion proteins of recombinant human and
porcine HMT expressed in bacteria as antigens for immu-
nizations of mice (Fig. 1), six clones were selected that
produced monoclonal antibodies with high binding speci-
ficity and affinity for human HMT (HYB372-04/-05/-06/-
07/-08/-09) and four clones for porcine HMT (HYB373-
02/-03/-04/-05). The selected antibodies strongly bound to
the respective recombinant HMT protein obtained by
thrombin cleavage of the GST fusion proteins used for
immunization (results not shown). Initial testing of these
monoclonal antibodies using human and porcine kidney
homogenates showed that all antibodies produced a single
strong band at 33 kDa and could be diluted up to 1:625,000
(Fig. 2a, b). Further testing of optimum antibody dilutions
using filter strips of human and porcine kidney homo-
genates gave suitable titers of 1:1000–1:10,000 for
different antibodies. Apart from HYB373-03 that showed a
weak reaction also with a ca. 40 kDa protein, none of the
monoclonal antibodies gave any additional bands when
tested with the kidney homogenates. Analysis of antibody
cross-reactivity showed that antibodies HYB373-02/-03
resulting from immunizations with porcine HMT also
reacted with a 33 kDa protein in human kidney homo-
genates (Fig. 2c) and that antibodies HYB372-07/-08/-09
resulting from immunizations with human HMT also
reacted with a 33 kDa protein in porcine kidney homo-
genates (Fig. 2d). The relative band intensities observed
with identical amounts of loaded protein and identical
antibody concentrations indicated that the cross-reacting
antibodies bound to the same protein in human and porcine
kidney lysates.
When probing total proteins of human and porcine
kidney lysates after separation by two-dimensional IEF/
SDS-PAGE with one of the cross-reacting antibodies
HYB372-07, a single spot was detected that migrated at ca.
33 kDa at a pH of ca. 5.0 for human kidney (Fig. 3b) and a
pH of ca. 5.5 for porcine kidney (Fig. 3d), which is in
excellent agreement with the molecular mass and pI values
calculated for the human and porcine HMT polypeptide
sequences, respectively. However, no spots were visible at
the respective positions of parallel Silver-stained gels
(Fig. 3a, c), indicating the low abundance of the protein in
kidney lysates. When blots of liver and kidney homo-
genates from different individuals were analyzed for the
presence of HMT using HYB372-05, the same sharply
focused band at 33 kDa was obtained in each case
(Fig. 3e), and the intensity of the band was proportional to
the HMT enzymatic activity in the respective sample
(Fig. 3f), confirming that the antibodies indeed bind to
HMT. Even on very long exposures, no significant other
bands were visible on the blot showing the absolute
specificity of the antibodies. With the most sensitive
enzymatic assay currently available [21] it is possible to
detect approximately 15 pg HMT. Using the blotting
technique with the monoclonal antibodies described here
we were able to reliably detect 1.5 pg HMT protein in a
dilution series of human liver and kidney homogenates
(results not shown), which translates into a ca. tenfold
higher sensitivity compared with the activity determina-
tion. This excellent sensitivity allows to exclude the
presence of significant amounts of HMT in samples where
HMT is not detectable by immunoblotting.
Histamine N-methyltransferase could be detected on
blots of all total human and porcine tissue homogenates
analyzed (results not shown), which is in accordance with
previous studies analyzing HMT enzymatic activity and
HMT mRNA in various porcine tissues [11]. In agreement
with HMT activity measurements, HMT could not be
detected on blots of total human and porcine blood plasma
proteins. Although HMT activity is below the limits of
detection in human urine, minute and individually variable
amounts of HMT were detectable on blots of all urine
samples analyzed.
We next tested whether the monoclonal antibodies
could detect HMT in tissue sections. When performing
immunohistochemical staining on human and porcine
kidney sections, identical staining patterns were obtained
with all antibodies at dilutions of 1:100–1:1500 as shown
exemplary for HYB372-04, HYB372-05, and HYB372-07
in Fig. 4. In both human and porcine kidney, there was
prominent staining of tubular epithelial cells (Fig. 4a, c,
e) and at higher magnification the staining was diffusely
spread over the whole cell as would be expected for an
evenly distributed cytosolic protein (Fig. 4b, d, f).
Besides, there was significant staining of a few isolated
cells that appeared to be monocytes or macrophages.
Although human erythrocytes have been described to
possess HMT activity [22] there was no clear staining of
these cells, which might be due to the low abundance of
the protein in erythrocytes. To confirm this assumption,
we prepared human erythrocyte lysates and were able to
detect minute amounts of HMT on blots and measure a
very low HMT activity. Compared with other cells, the
relative abundance of HMT in erythrocytes was found to
be much lower and apparently not sufficient for detection
by the less sensitive technique of immunohistochemical
staining.
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A comprehensive study investigating the expression
and cellular distribution of HMT in various human and
porcine tissues is under way and will be presented in a
separate communication. The results available so far
confirm earlier analyses of HMT activity measurement and
HMT mRNA expression in porcine tissues [11] showing
the presence of the enzyme in most tissues with a distinct
cellular localization. In accordance with the results of
immunohistochemical localization of HMT in guinea pig
tissues [23], human and porcine HMT appeared to be
moderately expressed in epithelial cells of the gastroin-
testinal tract, the urinary tract, the airway system, the skin,
and in hepatocytes. Besides, in most tissues analyzed so
far, HMT staining was prominent in a subset of
hematopoietic cells of the monocyte-macrophage and
dendritic cell lineages. From immunohistochemical stain-
ing, the overall HMT tissue levels represented by specific
enzymatic activity could be deduced from the expression
level in individual cells and the abundance of HMT
expressing cells in the respective tissue. Noteworthy,
immunohistochemical staining worked well also on sec-
tions from tissues processed for routine histopathological
evaluation by fixation in 10 % formaldehyde and embed-
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human kidney pig kidney
pig kidneyhuman kidney
Fig. 2 Test of antibody specificity, sensitivity, and cross-reactivity.
Filter strips containing approximately 5 lg human kidney homo-
genate (a, c) or 5 lg pig kidney homogenate (b, d) separated on a
10 % SDS polyacrylamide gel were incubated with the indicated
dilutions of the mouse monoclonal antibodies (1 mg/ml) for human
HMT (HYB372-04/-05/-06/-07/-08/-09) (a) or for pig HMT
(HYB373-02/-03/-04/-05) (b) in TBSTM. c, d Filter strips were
incubated with the indicated antibodies at a dilution of 1:10,000 in
TBSTM. Filter strips were then incubated with horseradish peroxi-
dase-conjugated anti-mouse immunoglobulins (1:1500 in TBSTM),
followed by ECL substrate, and exposure to film for 1 min (a) or
5 min (b, c, d). Sizes of molecular weight markers (M) are given in
kilodalton on the right and the migration position of HMT at 33 kDa
is indicated by arrows on the left. The band at ca. 55 kDa visible in
all lanes of (b) and (d) results from a weak cross-reaction of the anti-
mouse immunoglobulins with the large fragment of porcine IgG
present in the samples. The exact migration position of the visible
bands varies slightly in different lanes because filter strips from
different individual blots were used for this experiment
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To test the utility of the monoclonal antibodies for
investigations of HMT in human samples, we analyzed the
presence of HMT in a series of consecutive control biop-
sies of kidney and liver transplant tissue obtained for
routine diagnostic procedures (Fig. 5). Using blots of
homogenates prepared from minute amounts of tissue not
used for histological assessment, HMT was clearly
detectable in just 2 lg of total protein loaded and showed
human kidney
[M = 33.30 kDa, pI = 4.98]
pig kidney
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Fig. 3 Detection of HMT on 2D-IEF/SDS-PAGE gels and correla-
tion of band intensity with HMT activity. Ten microgram each of a
human kidney homogenate (a, b) or a porcine kidney homogenate (c,
d) was separated by isoelectric focusing on a pH 3–10 gradient IEF
gel followed by size separation on a 10 % SDS polyacrylamide gel.
Gels were either silver-stained (a, c) or blotted onto PVDF
membranes (b, d). For detection of HMT, blots were incubated with
HYB372-07 (1:6000 in TBSTM) and horseradish peroxidase-conju-
gated anti-mouse immunoglobulins (1:1500 in TBSTM), followed by
ECL prime substrate, and exposure to film for 1 min. The molecular
mass and pI values calculated for the human and porcine HMT
proteins are given in square brackets on top of the gels. e 2 lg each of
four different human liver homogenates (lanes 1–4) and four different
human kidney homogenates (lanes 5–8) were separated on a 10 %
SDS polyacrylamide gel, blotted onto PVDF membrane, and HMT
was detected by incubation with HYB372-05 (1:6000 in TBSTM) and
horseradish peroxidase-conjugated anti-mouse immunoglobulins
(1:1500 in TBSTM), followed by ECL prime substrate, and exposure
to film for 1 min. f Integrated intensity determined for the bands on
the blot in (e) using ImageJ was plotted against the HMT activity in
the respective sample. A Pearson’s correlation coefficient of 0.983
with p\ 0.01 was obtained for this correlation using SPSS Statistics
19 (SPSS Inc., Chicago, USA). Sizes of molecular weight markers
(M) are given in kilodalton and the migration position of HMT at ca.
33 kDa is indicated by arrows
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considerable variation of abundance in different kidney and
liver grafts. Although HMT could easily be quantitated
from these blots by scanning the band intensities, exact
quantification in a routine setting would certainly warrant
development of a simpler and faster ELISA test. All HMT
monoclonal antibodies should work fine in an ELISA
because this was the procedure used for original screening
of the antibody clones. Further studies are in progress to
clarify the variations in HMT levels in kidney and liver
grafts and to assess if this parameter might be diagnosti-
cally useful. In any case, this study demonstrates the
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Fig. 4 Immunohistochemical staining of kidney sections. Thin
sections of human kidney (a, b, c, d) and pig kidney (e, f) were
incubated with HYB372-04 (a, b, diluted 1:1000 in TNB), HYB372-
05 (c, d, diluted 1:1000 in TNB), and HYB372-07 (e, f, diluted 1:500
in TNB), respectively. Following incubation with horseradish perox-
idase-conjugated secondary antibodies and tyramide signal
amplification, slides were developed with 3,30-diaminobenzidine
(brown staining of immunocomplexes) and counterstained with
Mayer’s hemalum (blue staining of nuclei and cell membranes).
Control incubations omitting the primary antibody (g) or pre-
incubating the primary antibody with a 25-fold molar excess of the
respective recombinant antigen used for immunization (h) produced
no staining. Staining of parallel sections with an antibody specific for
the cytosolic marker glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) produced a very similar staining pattern as the HMT-
specific antibodies (i) except for the fact that GAPDH stains all cells,
whereas HMT staining is restricted to specific cells. Slides were
photographed at 1009 (a, c, e), 4009 (b, d, f), and 509 (g, h,
i) enlargement
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samples making use of the excellent sensitivity of the new
HMT antibodies.
Discussion
A series of monoclonal antibodies exhibiting a high
specificity and sensitivity for human and porcine HMT,
respectively, was obtained by immunizing mice with HMT
proteins expressed in vitro. All antibodies recognized a
single protein band of 33 kDa corresponding to monomeric
HMT on immunoblots of tissue homogenates and except
for HYB373-03 did not bind to any other human or porcine
protein in the samples analyzed. With these antibodies it
was possible to detect HMT with tenfold higher sensitivity
than with the most sensitive radioenzymatic assay in use
[21]. Furthermore, these antibodies work excellent in
immunohistochemical staining of human and porcine tissue
sections and thus facilitate the sensitive and specific
detection of the HMT protein at the cellular and subcellular
level.
The specificity of the antibodies was demonstrated by
detection of a single band of the expected size of 33 kDa
on immunoblots of different human and porcine samples
(Fig. 2a, b), correlation of the intensity of this band with
HMT activity in the respective sample (Fig. 3e, f), and
detection of a single spot of expected size and pI value on
blots of two-dimensional gels of human and porcine kidney
homogenates, respectively (Fig. 3b, d). Although not pre-
sented here, we also performed immunoprecipitation
experiments that showed that HYB272-04/-05/-06/-08/-09
and HYB373-03 but not HYB372-07 and HYB373-02/-
04/-05 precipitated HMT from human and porcine kidney
and liver lysates prepared under non-denaturing conditions,
indicating that these antibodies also bind to the native
HMT protein. As was evident from antibody dilution
experiments, different antibodies exhibited outstanding but
different sensitivities for the detection of HMT on immu-
noblots of tissue homogenates (Fig. 2a, b) and in
immunohistochemical staining. Furthermore, HYB372-
04/-05/-06 bound only human HMT, HYB373-04/-05























































































































































































































































Fig. 5 Analysis of HMT in human transplant tissue. Aliquots of
tissue samples from 108 consecutive control biopsies of human
kidney (green numbers marked with plus sign, n = 85) and liver (blue
numbers marked with hash, n = 23) grafts obtained for routine
diagnostic procedures were homogenized and cleared by centrifuga-
tion. For each sample, 2 lg total protein was separated on a 10 %
SDS polyacrylamide gel, blotted onto a PVDF membrane and HMT
was detected with HYB372-07 (1:6000 in TBSTM) and horseradish
peroxidase-conjugated anti-mouse immunoglobulins (1:1500 in
TBSTM), followed by ECL Prime substrate, and exposure to film
for 1 min. Sizes of molecular weight markers (M) are given in
kilodalton on the left. The exact migration position of HMT at ca.
33 kDa varies slightly in different lanes due to the different salt
concentration in individual samples
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and HYB373-02/-03 bound both human and porcine HMT
(Fig. 2c, d). Therefore, our collection contains both anti-
bodies recognizing species-specific epitopes but also
common epitopes and these might be useful for analyses of
HMT in other species.
All antibodies detected HMT by immunohistochemical
staining of tissue sections and produced identical staining
patterns when used at optimum concentration (Fig. 4). In
all tissues analyzed so far, we observed relatively uniform
staining of specific cells as would be expected for a sol-
uble cytosolic protein. Although a cytosolic localisation of
HMT could be deduced from the facts that mammalian
HMT polypeptide sequences (Fig. 1c) lack sorting signals
for other cellular compartments and that HMT activity is
usually associated with the soluble fraction obtained by
differential centrifugation of cell lysates [15, 24, 25], we
here provide direct immunohistochemical evidence for the
subcellular localisation of the protein in man and pig. Our
findings are in accordance with results of HMT localisa-
tion experiments in human astrocytes reported by
Yoshikawa and colleagues [26]. As will be reported
elsewhere, HMT was found to be present in epithelial
cells of the gastrointestinal tract, the urinary tract, the
airway system, the skin, and in hepatocytes, which agrees
well with immunohistochemical analysis of HMT
expression in guinea pigs [23]. Additionally, prominent
HMT staining was found in human and porcine
hematopoietic cells that morphologically appeared to be
macrophages and dendritic cells but this has to be con-
firmed by staining with cell-specific markers. We did not
see HMT staining of blood vessels or neuronal cells as
has been reported in the bovine nervous system [27] and it
is not clear if this is due to species differences or antibody
specificity. We also did not see HMT staining of ery-
throcytes, where the sensitivity of immunohistochemistry
appears not to be sufficient to detect the low levels of the
enzyme present in these cells [22]. Given the cytosolic
localisation of HMT, it will be interesting to analyze if
HMT expressing cells also express histamine receptors
[1, 2] and/or transporters that could mediate histamine
uptake [28–30] to clarify the physiological role of the
enzyme in histamine inactivation.
We also included a small exploratory study analyzing
HMT in minute amounts of samples from control biopsies
of kidney and liver grafts (Fig. 5) to demonstrate that the
antibodies described here can be used in a routine setting. It
is apparent from the blots that the amount of HMT protein
varies significantly in different samples, where we care-
fully checked protein loading and protein patterns of
parallel silver-stained gels and verified uniform HMT
staining of the tissue sections, from which the samples for
protein analysis had been obtained. Detailed evaluation of
these differences in HMT tissue levels and correlation with
organ quality and function is certainly worthwhile espe-
cially for the kidney, where the selection of non-invasive
biomarkers for injury and function is very limited [31]. As
kidney injury is usually associated with changes in the
urine, it is interesting to note that both histamine inacti-
vating enzymes HMT and DAO can be detected in human
urine with the antibodies described here and earlier [13]
although the enzymatic activities are beyond the limits of
detection. If found to be diagnostically useful, a routine
ELISA test for HMT determination in human urine could
easily be set up with these antibodies.
In conclusion, the ten monoclonal HMT antibodies
described here represent excellent tools for the sensitive
and specific detection of the human and porcine HMT
proteins allowing a comprehensive evaluation of the
expression and cellular localization of the enzymes in man
and pig. Furthermore, these antibodies will facilitate a
better understanding of the role of HMT in histamine
inactivation in different cell types as well as sensitive
analyses of disease-associated alterations of the enzyme.
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